FMI predicts vaccines market to reach a valuation of US $120B by 2032. Key Players - Merck & Co., Inc, GlaxoSmithKline, Pfizer BioNTech; Sanofi SA, CSL Limited, Emergent Biosolutions Inc., Johnson & Johnson (J&J), AstraZeneca plc, Bavarian Nordic A/S, and Mitsubishi Tanabe Pharma Corporation.